Donald R. Fleming

Phase II study of tariquidar, a selective P‐glycoprotein inhibitor, in patients with chemotherapy‐resistant, advanced breast carcinoma

Lajos Pusztai, Peter J. Wagner, Nuhad K. Ibrahim et al. · Cancer · 2005 · 300 citations · Full text

Medicine, Oncology, Pharmacology +15

Pure red cell aplasia due to parvovirus B19 in a patient treated with rituximab

Vivek R. Sharma, Donald R. Fleming, Stephen P. Slone · Blood · 2000 · 125 citations

Life Sciences, Hematology, Immunology +4

Docetaxel-carboplatin as first line chemotherapy for epithelial ovarian cancer

P. Vasey, R. Atkinson, Robert E. Coleman et al. · British Journal of Cancer · 2001 · 80 citations · Full text

Medicine, Oncology, Pharmacology +12

A phase II study of DT fusion protein denileukin diftitox in patients with fludarabine-refractory chronic lymphocytic leukemia.

Arthur E. Frankel, Donald R. Fleming, Philip D. Hall et al. · PubMed · 2003 · 73 citations

Medicine, Hematology, Pharmacotherapy +17

Impact of obesity on allogeneic stem cell transplant patients: A matched case-controlled study

Donald R. Fleming, Mary Kay Rayens, Juanita Garrison · The American Journal of Medicine · 1997 · 67 citations

Medicine, Hematology, Surgery +14